| |
 |
|
 An internal e-mail from AstraZeneca Plc showed that the drug company hided some unfavorable studies on its antipsychotic drug Seroquel. The e-mail was unsealed as part the legal suit over the medicine. AstraZeneca didn’t publish the results of three clinical trials made on Seroquel and instead it picked only the information used from the...
 |
|
|
 A new study showed that the fampridine drug may help the patients who suffer from multiple sclerosis by improving their walking ability. Phase III of the study tracked 301 patients aged 18 to 70. All the patients received either 10 milligrams of fampridine or a placebo twice a day for 14 weeks.The walking speed of the patients started to...
|
|
|
 It appears that a combination of two
existing drugs may offer great promise in the fight against the most dangerous
form of tuberculosis. The drugs in question are AstraZeneca’s Merrem I.V., also
called meropenem and GlaxoSmithKline’s clavulanate, in combination with amoxicillin.
According to studies made in the
laboratory, the...
|
|
|
The Food and Drug Administration announced
its decision to require all manufacturers of metoclopramide, a drug which is
usually prescribed to treat gastrointestinal disorders, to add a boxed warning
to their drug labels about the drug’s side effects. The drug is sold like
tablets, syrups and injections as Reglan Tablets, Reglan Oral...
|
|
|
 Amazing as it sounds, the experimental drug fampridine (4-aminopyiridine) can actually improve walking ability in some individuals with multiple sclerosis (MS). This is the conclusion of a multi-center Phase 3 clinical trial and these results have been published in the February 26 journal The Lancet. Andrew Goodman, chief of the Multiple...
|
|
|
 A combination of two B vitamins and folic
acid was found to protect women against age-related macular degeneration, the
leading cause of blindness in the elderly, according to a study published in
the Feb. 23 Archives of Internal Medicine.
Researchers at Brigham and Women's Hospital
in Boston, who
conducted the study, said that...
|
|
|
Prasugrel, made by Eli Lilly and Co. in a
joint with Daiichi Sankyo Co., Ltd., was approved for heart patients with acute
coronary syndrome undergoing an artery-opening procedure. The condition includes
heart attacks and chest pain. The drug is aimed at decreasing the platelets’
capacity to stick or bundle up together, which can...
|
|
|
<!--
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{mso-style-parent:"";
margin:0cm;
margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:12.0pt;
font-family:"Times New Roman";
mso-fareast-font-family:"Times New Roman";}
@page Section1
{size:612.0pt...
|
|
|
The Food and Drug Administration has received reports of three confirmed cases and one possible case of progressive multifocal leukoencephalopathy in patients taking Raptiva. Three patients taking Raptiva died. As a result, the FDA issued a public health advisory about these reports. The agency is reviewing the reports of PML in Raptiva...
|
|
|
 A severe form of epilepsy called Lennox-Gastaut syndrome will be treated with a new drug called Banzel, which has been approved by the Food and Drug Administration on Friday as an extra supplement against the terrible disease. The FDA approved the drug after several tests were made.Patients aged between 4 and 30 years old were the...
|
|
|
|
 |
 Mass Murder in Memphis Home, 6 Killed
The bodies of six people - 4 adults and 2 children - were found by police in a small brick house in Memphis, Tennessee. Inside the small building were found three other...
|
|
|
|
| |
|
